---

10 Dec 2008 : Column 150W—continued

Departmental Manpower

Mr. Lansley: To ask the Secretary of State for Health if he will place in the Library a copy of his Department's workforce planning assumptions used to inform the 2007 Comprehensive Spending Review. [241150]

Mr. Bradshaw: We do not publish planning assumptions relating to the comprehensive spending review.

Departmental Official Hospitality

David Simpson: To ask the Secretary of State for Health what records his Department maintains of its expenditure on (a) official hospitality and (b) alcohol for official hospitality. [240470]

Mr. Bradshaw: The Department’s central financial recording system captures information on expenditure under the headings of ‘working lunches’ and ‘hospitality’. No separate records of expenditure on alcohol are maintained.

Departmental Private Finance Initiative

Mr. Lansley: To ask the Secretary of State for Health how much his Department spent on cancelled private finance initiative projects since 1997; what the project was in each case; and on what date each such project was cancelled. [241339]

Mr. Bradshaw: Since 1997 the Department has agreed compensation payments in respect of abortive bidding costs at two private finance initiative (PFI) schemes, either as a direct result of a cancellation or at a scheme which later went on to be cancelled. Details of the payments are:

£7.3 million in respect of the Essex Rivers Healthcare NHS Trust PFI scheme cancelled in June 2006; the Department paid the full amount directly to the bidders in March 2007; and

£9.1 million in respect of abortive costs resulting from the decision of the Department's PFI review in August 2006 to reduce the scope of the University of Leicester Hospitals NHS Trust scheme. 80 per cent. of the settlement—£7.2 million—was met by the Department and paid to the trust for disbursement via an adjustment to the local primary care trusts (PCTs) revenue allocations in May 2007. The trust contributed £2.1 million. The scheme was subsequently cancelled in July 2007.

Mr. Lansley: To ask the Secretary of State for Health what the capital value is of each private finance initiative scheme overseen by his Department which has reached financial close; and, for each such scheme, (a) over what period repayments will take place and (b) what the cost of repayment will be expressed in (i) real and (ii) cash terms. [241340]

Mr. Bradshaw: The information requested has been placed in the Library.

Departmental Public Consultation

Mr. Graham Stuart: To ask the Secretary of State for Health how much his Department spent on national consultations in each of the last five years; and if he will make a statement. [240552]

Mr. Bradshaw: The Department does not hold information centrally about the costs of public consultations. Information on the Department’s expenditure on public consultations can be obtained only at disproportionate cost.

Departmental Training

Mr. Lansley: To ask the Secretary of State for Health which staff members attended his Department's departmental board away day held on 11 and 12 September 2008; and how much was claimed in total in expenses relating to the away day by such staff. [241147]

10 Dec 2008 : Column 151W

Mr. Bradshaw: The following departmental staff attended the departmental board away day on 11 and 12 September 2008:

Hugh Taylor (Permanent Secretary)

David Nicholson (NHS Chief Executive)

Liam Donaldson (Chief Medical Officer)

David Behan (Director General Social Care, Local Government and Care Partnerships)

Richard Douglas (Director General for Finance and Chief Operating Officer)

Richard Mundon (Director of Operations)

Ralph Coulbeck (Policy Adviser, Office of NHS Chief Executive)

Alison Ismail (Principal Private Secretary to the Permanent Secretary)

Stephen Mitchell (Head of Governance).

The total amount of expenses claimed by those who attended the away day was £626.20. This includes train fares to and from the hotel.

Mr. Lansley: To ask the Secretary of State for Health where his Department's departmental board away day which took place on 11 and 12 September 2008 was held. [241148]

Mr. Bradshaw: The Department's departmental board away day held on 11 and 12 September 2008 was held at Great Fosters hotel, Stroude road, Egham, Surrey TW20 9UR.

Mr. Lansley: To ask the Secretary of State for Health if he will place in the Library copies of the (a) agenda and (b) minutes of his Department's departmental board away day held on 11 and 12 September 2008. [241149]

Mr. Bradshaw: No formal minutes were produced of the departmental board away day, held on 11 and 12 September. An informal note was produced, and this, with the agenda, has been placed in the Library.

Diabetes

Mr. Sanders: To ask the Secretary of State for Health how many patients on the diabetes register there were in each primary care trust area in each of the last three years for which figures are available. [240296]

Ann Keen: The national Quality and Outcomes Framework (QOF) records the number of people recorded on practice diabetes registers, and counts are available for the years 2005-06 to 2007-08. The figures are available by primary care trust (PCT). The diabetes register only includes patients aged 17 years and over, as the care of children with diabetes is generally under the control of specialists.

2007-08 data are contained in ‘PCT level QOF tables’, which has been placed in the Library. It is also available at the following link:

http://www.ic.nhs.uk/statistics-and-data-collections/supporting-information/audits-and-performance/the-quality-and-outcomes-framework/qof-2007/08/data-tables

The table in question can be found in the section ‘PCT level QOF tables’ at this link: ‘PCT level QOF tables 2007/08—prevalence.xls’.

10 Dec 2008 : Column 152W

2006-07 data are contained in ‘PCT QOF tables’, which has been placed in the Library. It is also available at the following link:

http://www.ic.nhs.uk/statistics-and-data-collections/supporting-information/audits-and-performance/the-quality-and-outcomes-framework/qof-2006/07/qof-2006-07-data-tables

The table in question can be found in the section ‘PCT QOF tables’ at this link: ‘PCT QOF tables 2006-07—prevalance.xls’.

2005-06 data are contained in ‘Disease prevalence at PCT level’, which has been placed in the Library. It is also available at the following link:

http://www.ic.nhs.uk/statistics-and-data-collections/supporting-information/audits-and-performance/the-quality-and-outcomes-framework/qof-2005/06/qof-2005-06-detailed-spreadsheets

The table in question can be found in the section ‘QOF Achievement Data at General Practice Level’ at this link: ‘Disease prevalence at PCT level’.

Miss McIntosh: To ask the Secretary of State for Health how many people were diagnosed in (a) North Yorkshire and (b) England with (i) type one diabetes and (ii) type two diabetes in each year since 1997. [241971]

Ann Keen: The Quality and Outcomes Framework (QOF) records the number of people recorded on general practice diabetes registers in England. As the care of children with diabetes is generally under the control of specialists, the register excludes those patients age 16 and under.

The following table shows the number of people with type 1 and type 2 diabetes recorded on diabetes registers from 2004-05 to 2007-08, for the years for which data are available.

Quality and outcomes framework (QOF) diabetes register counts( 1)
Financial year	2004-05	2005-06	2006-07	2007-08
North Yorkshire and York PCT(2)	22,777	24,346	25,682	27,329
England	1,766,391	1,890,666	1,961,976	2,088,335
(1 )The diabetes registers make no distinction between type 1 and type 2 diabetes. (2 )The figures for 2004-05 and 2005-06 are the sum of the diabetes registers for the health areas that make up the North Yorkshire area, the details of which are given as follows: Craven, Harrogate and Rural District; Hambleton and Richmondshire; Scarborough, Whitby and Ryedale; and Selby and York.

Diabetes: Health Services

John Bercow: To ask the Secretary of State for Health what progress has been made on the three pilots undertaken as part of the Diabetes Year of Care Project. [240360]

Ann Keen: The three Year of Care pilot areas, Calderdale and Kirklees primary care trusts (PCTs), Tower Hamlets PCT and NHS North of Tyne, have now completed the first phase of the three-year project, which has focused on preparing systems and workforce to enable the delivery of the Year of Care approach. The pilots are now beginning to deliver the Year of Care programme to people with diabetes in their area.

10 Dec 2008 : Column 153W

In October 2008 the Year of Care team launched “Getting to grips with the Year of Care: a practical guide” to help spread the learning acquired during the preparatory phase. An evaluation report, “Evaluating pilot sites as they prepare for the Year of Care: Final project report”, is also available. This document has been placed in the Library.

Drugs: Misuse

Mike Penning: To ask the Secretary of State for Health how many people residing in London are estimated to have used (a) Class A drugs and (b) any illegal drugs in the last year for which figures are available. [240586]

Dawn Primarolo: According to the 2007-08 British Crime Survey (BCS), 3.7 per cent. of the population aged 16-59 years of age in London reported use of any Class A drug in the last year and 9.2 per cent. reported use of any illicit drug in the last year. It is not possible to provide robust estimates of the number of 16 to 59-year-olds who have taken drugs in London from the BCS.

Mike Penning: To ask the Secretary of State for Health how many drugs-related hospital admissions were recorded in London in each of the last five years. [240587]

Dawn Primarolo: The information requested is in the following table. The system of diagnostic codes used to classify admission to hospital does not distinguish between recreational, illicit misuse or medical use of drugs. The diagnostic codes used are listed in the following table.

10 Dec 2008 : Column 154W

10 Dec 2008 : Column 155W

	Number of total admissions
2006-07	25,782
2005-06	25,148
2004-05	21,938
2003-04	18,810
2002-03	16,069
Notes: 1. Finished admission episodes: A finished admission episode is the first period of in-patient care under one consultant within one health care provider. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. 2. The ICD-10 codes used to identify a drug related diagnosis are as follows. It is not possible to identify in ICD-10 all diseases caused by drugs (legal or illegal) and there is no way to guarantee, that the admission was drug related. For example, a patient admitted for inguinal hernia surgery may also be dependent on a drug. F11—Mental and behavioural disorders due to use of opioids F12—Mental and behavioural disorders due to use of cannabinoids F13—Mental and behavioural disorders due to use of sedatives or hypnotics F14—Mental and behavioural disorders due to use of cocaine F15—Mental and behavioural disorders due to use of other stimulants, including caffeine F16—Mental and behavioural disorders due to use of hallucinogens F18—Mental and behavioural disorders due to use of volatile solvents F19—Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances F55—Abuse of non-dependence-producing substances K71.0—Toxic liver disease with cholestasis K71.1—Toxic liver disease with hepatic necrosis K71.2—Toxic liver disease with acute hepatitis K71.3—Toxic liver disease with chronic persistent hepatitis K71.4—Toxic liver disease with chronic lobular hepatitis K71.5—Toxic liver disease with chronic active hepatitis K71.6—Toxic liver disease with hepatitis, not elsewhere classified K71.7—Toxic liver disease with fibrosis and cirrhosis of liver K71.8—Toxic liver disease with other disorders of liver K71.9—Toxic liver disease, unspecified T36—Poisoning by systemic antibiotics T37—Poisoning by other systemic anti-infectives and antiparasitics
T38—Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified T39—Poisoning by nonopioid analgesics, antipyretics and antirheumatics T40—Poisoning by narcotics and psychodysleptics (hallucinogens) T41—Poisoning by anaesthetics and therapeutic gases T42—Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs T43—Poisoning by psychotropic drugs, not elsewhere classified T44—Poisoning by drugs primarily affecting the autonomic nervous system T45—Poisoning by primarily systemic and haematological agents, not elsewhere classified T46—Poisoning by agents primarily affecting the cardiovascular system T47—Poisoning by agents primarily affecting the gastrointestinal system T48—Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system T49—Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs T50—Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances T52—Toxic effect of organic solvents T53—Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons T54—Toxic effect of corrosive substances T55—Toxic effect of soaps and detergents T56—Toxic effect of metals T57—Toxic effect of other inorganic substances T58—Toxic effect of carbon monoxide T59—Toxic effect of other gases, fumes and vapours T60—Toxic effect of pesticides T61—Toxic effect of noxious substances eaten as seafood T62—Toxic effect of other noxious substances eaten as food T63—Toxic effect of contact with venomous animals T64—Toxic effect of aflatoxin and other mycotoxin food contaminants T65—Toxic effect of other and unspecified substances X40—Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics X41—Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified X42—Accidental poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified X43—Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system X44—Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances X46—Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours X47—Accidental poisoning by and exposure to other gases and vapours X48—Accidental poisoning by and exposure to pesticides X49—Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances X60—Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics X61—Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified X62—Intentional self-poisoning by and exposure to narcotics and psychodysleptics (hallucinogens), not elsewhere classified X63—Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system X64—Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances X66—Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours X67—Intentional self-poisoning by and exposure to other gases and vapours X68—Intentional self-poisoning by and exposure to pesticides X69—Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances Y40—Systemic antibiotics Y41—Other systemic anti-infectives and antiparasitics Y42—Hormones and their synthetic substitutes and antagonists, not elsewhere classified Y43—Primarily systemic agents Y44—Agents primarily affecting blood constituents Y45—Analgesics, antipyretics and anti-inflammatory drugs Y46—Antiepileptic and antiparkinsonism drugs Y47—Sedatives, hypnotics and antianxiety drugs Y48—Anaesthetics and therapeutic gases Y49—Psychotropic drugs, not elsewhere classified Y50—Central nervous system stimulants, not elsewhere classified Y51—Drugs primarily affecting the autonomic nervous system Y52—Agents primarily affecting the cardiovascular system Y53—Agents primarily affecting the gastrointestinal system Y54—Agents primarily affecting water-balance and mineral and uric acid metabolism Y55—Agents primarily acting on smooth and skeletal muscles and the respiratory system Y56—Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs Y57—Other and unspecified drugs and medicaments Y58—Bacterial vaccines Y59—Other and specified vaccines and biological substances T80.0—Air embolism following infusion, transfusion and therapeutic injection
T80.1—Vascular complications following infusion, transfusion and therapeutic injection T80.2—Infections following infusion, transfusion and therapeutic injection T80.8—Other complications following infusion, transfusion and therapeutic injection T80.9—Unspecified complication following infusion, transfusion and therapeutic injection T88.0—Infection following immunisation T88.1—Other complications following immunisation, not elsewhere classified T88.2—Shock due to anaesthesia T88.3—Malignant hyperthermia due to anaesthesia T88.5—Other complications of anaesthesia T88.6—Anaphylactic shock due to adverse effect of correct drug or medicament properly administered T88.7—Unspecified adverse effect of drug or medicament Z71.5—Drug abuse counselling and surveillance T96.X—Sequelae of poisoning by drugs, medicaments and biological substances 3. London Strategic Health Authority of Treatment: In 2006-07 London as a whole was a strategic health authority (SHA). Pre 2006-07 London was made up of five SHAs. 2006-07: London SHA Pre 2006-07: North West London; North Central London; North East London; South East London; South West London 4. Ungrossed Data: Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed). Source: Hospital Episode Statistics, The NHS Information Centre for health and social care

---